Apollo Medical Holdings, Inc.

$ 40.82 -2.11 %

Apollo Medical Holdings, Inc. (AMEH) is a technology-driven healthcare firm that centers its operations around its medical practitioners to deliver comprehensive healthcare solutions. The company utilizes its proprietary platform for population health management and care provisioning, running an integrated, value-focused healthcare model. This framework enables its network of practitioners to furnish comprehensive patient care. AMEH provides meticulously coordinated care for a wide array of parties, including individual patients, their relatives, general practitioners, medical specialists, acute care facilities, other inpatient settings, various physician organizations, and health insurance providers. Its clinical team includes general practitioners, specialized doctors, and hospital-based physicians. Primarily serving the California populace, it attends to patients with diverse insurance coverage—including private plans, government programs like Medicare and Medicaid, and HMOs—as well as those who are uninsured. Founded in 1994, the company maintains its corporate headquarters in Alhambra, California.

CEO: Brandon Sim - https://www.apollomed.net

Price objectif

$48.5 18.81 %

Recommandation

Buy

DCF

$ 0.00

Loading data...

AMEH vs S&P500

Loading data...

No data available.

Quick ratio

1.35

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

39.25

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

1.04

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

3.88 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

3.23 %

generates a return higher than the cost of its capital, thereby creating value for its investors.

WACC

-

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

1.33

means it relies more on debt, which can increase financial risk.

Free cash flow per share

3.17

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

8.38 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
5 indicates moderate financial health
Altman score
2.53 indicates an uncertain financial situation
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.64 indicates that the company has a moderate ability to cover its short-term debts with its cash
Debt Ratio
0.45 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.